These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
692 related articles for article (PubMed ID: 33760128)
1. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis. Pang R; Yang S Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4. Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p. Chen Y; Li Y; Gao H Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1. Yin JJ; Cheng XY Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3431-3439. PubMed ID: 31081097 [TBL] [Abstract][Full Text] [Related]
5. LINC00311 promotes cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in human papillary thyroid cancer. Gao Y; Wang F; Zhang L; Kang M; Zhu L; Xu L; Liang W; Zhang W Cancer Med; 2020 Feb; 9(4):1515-1528. PubMed ID: 31894666 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression. Sun Y; Shi T; Ma Y; Qin H; Li K Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502 [TBL] [Abstract][Full Text] [Related]
7. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3. Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer. Gao H; Sun X; Wang H; Zheng Y Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764 [TBL] [Abstract][Full Text] [Related]
10. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p. Wang D; Zheng Y Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561 [TBL] [Abstract][Full Text] [Related]
11. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
12. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096 [TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA‑DUXAP8 regulates TOP2A in the growth and metastasis of osteosarcoma via microRNA‑635. Yang T; Guo JP; Li F; Xiu C; Wang H; Duan XL Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982765 [TBL] [Abstract][Full Text] [Related]
14. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma. Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918 [TBL] [Abstract][Full Text] [Related]
15. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2. Zhao Y; Zhao L; Li J; Zhong L J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261 [TBL] [Abstract][Full Text] [Related]
16. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma. Meng XF; Zhao LY; Chu XF Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752 [TBL] [Abstract][Full Text] [Related]
17. Suppression of long noncoding RNA LINC00324 restricts cell proliferation and invasion of papillary thyroid carcinoma through downregulation of TRIM29 via upregulating microRNA-195-5p. Xu J; Li Z; Su Q; Zhao J; Ma J Aging (Albany NY); 2020 Dec; 12(24):26000-26011. PubMed ID: 33318312 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value. Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950 [TBL] [Abstract][Full Text] [Related]
19. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis. Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306 [TBL] [Abstract][Full Text] [Related]
20. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis. Li G; Kong Q Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]